课题基金 / 基金详情

Lymphocyte Transformation Test is unreliable for the diagnosis of kampo-medicine-induced liver injury.

Lymphocyte Transformation Test is unreliable for the diagnosis of kampo-medicine-induced liver injury.
淋巴细胞转化试验对于汉方药引起的肝损伤的诊断并不可靠。
批准号:
15590596
负责人:
MANTANI Naoki
金额:
$0.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
为了解汉方药物促分裂活性对淋巴细胞转化试验(LTT)的实际影响,我们对一生中未服用汉方药物的患者进行了4种中药的淋巴细胞转化试验,并首次咨询了我科。14例患者入选当归、黄芩,4例患者入选柴胡、甘草。正在接受皮质类固醇或免疫抑制药物治疗或经历过药物过敏的患者被排除在外。每种草药(5g)加入600毫升水中,煮30分钟。浓缩后的提取物与从入选患者身上获得的血液样本一起被提交给生物医学实验室(BML,Inc.)。为了验证中药在临床情况下LTT的实际情况下的效果,采用BML,Inc.进行了LTT的测量,其中12例Toki和Ogon的LTT均为阳性。4例Saiko的LTT均阳性,3例Kanzo的LTT阳性。患者未见嗜酸性粒细胞增多或肝损伤。在本研究中,我们对一生中没有服用过坎布族药物的患者进行了LTT。这些发现表明,中草药的LTT有可能产生假阳性结果,LTT对Kampo药物所致肝损伤的诊断是不可靠的。
英文摘要
To examine actual impact of mitogenic activity by Kampo medicine on the lymphocyte transformation test(LTT), we conducted LTT for four herbs in patients who had taken no Kampo medicine in their life and consulted our department for the first time. Fourteen patients were enrolled for Toki (Angelicae Radix) and Ogon (Scutellariae Radix), and 4 patients were enrolled for Saiko (Bupleuri Radix) and Kanzo (Glycyrrhizae Radix). Patients who were being treated with corticosteroids or immunosuppresive drugs or who had experienced drug allergy were excluded. Each herb (5g) was added to 600 ml of water and boiled for 30 min. The boiled-down extract was submitted to Bio Medical Laboratories (BML, Inc.Japan), along with blood samples obtained from the enrolled patients. To examine the effects of herbs under the actual conditions of the LTT in the clinical situation, measurement of LTTs were performed as described previously ^<2)>by BML, Inc.LTT for both Toki and Ogon were positive in 12 of 14 patients. LTT for Saiko was positive in all 4 patients and LTT for Kanzo was positive in 3 of 4 patients. No eosinophilia or liver injury was observed in the patients. In the present study, we conducted LTT for these herbs in patients who had taken no Kampo medicine in their life. These findings suggests that LTT for the herbs are likely to yield false-positive results and LTT is unreliable for the diagnosis of Kampo-medicine-induced liver injury.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
薬物性肝障害の診断基準の作成における問題について
制定药物性肝损伤诊断标准的问题
DOI: --
发表时间: 2004
期刊: 肝臓 45
影响因子: --
作者: [萬谷 直樹]
通讯作者: 萬谷 直樹
漢方薬による肝障害に対する薬物性肝障害診断基準の感度と特異度
药物性肝损伤诊断标准对中药性肝损伤的敏感性和特异性
DOI: --
发表时间: 2004
期刊: 肝臓 45・7
影响因子: --
作者: [萬谷 直樹, 萬谷直樹, 萬谷直樹]
通讯作者: 萬谷直樹
漢方薬による肝障害に対する薬物性障害診断基準の感度と特異度
中药肝损伤药源性疾病诊断标准的敏感性和特异性
DOI: --
发表时间: 2004
期刊: 肝臓 45
影响因子: --
作者: [K.Yoshimoto, S.Komura, M.Yasuhara, 萬谷 直樹]
通讯作者: 萬谷 直樹
Kampo medicine and new criteria for diagnosis of drug-induced liver injury : Sensitivity and Specificity.
汉方医学和药物性肝损伤诊断新标准:敏感性和特异性。
DOI: --
发表时间: 2004
期刊: Kanzo 45
影响因子: --
作者: [M.Yoshida, A.Akane, M.Nishikawa, H.Tsuchihashi, Mantani N.]
通讯作者: Mantani N.
共 14 条
    海外基金